| Name | Title | Contact Details |
|---|
VersaSuite is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Emergent Health Corp. is a public company (trading under the symbol EMGE) dedicated to the betterment of its shareholders and product consumers. We believe we have a developing product line to become a leader in the field of Regenerative Medicine and improved neutraceuticals and phytonutritionals to be available to the general public without a prescription.
Hello Phoenix is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Michele Bally, Pharmaconsult Inc is a Montrí©al-Ouest, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.